Huntington's disease is caused by an alteration in the huntingtin (HTT) gene on chromosome 4, leading to the production of a harmful protein that progressively deteriorates brain function.
Inhibiting LRRK2 both pharmacologically and genetically in mice reduced haloperidol's side effects, suggesting potential strategies to mitigate its harmful impacts on motor function.
"I was having spasms all over and I still kind of do. They don't really know. For a while, they told me I was dying. Literally within this last year, they told me that."